Exact Mass: 430.98195300000003
Exact Mass Matches: 430.98195300000003
Found 31 metabolites which its exact mass value is equals to given mass value 430.98195300000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Benzthiazide
C15H14ClN3O4S3 (430.98349540000004)
Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
Pimasertib
C15H15FIN3O3 (431.01421619999996)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Pimasertib (AS703026) is a highly selective, ATP non-competitive allosteric orally available MEK1/2 inhibitor[1][2].
N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide
C17H10Cl2F3N3O3 (431.00512860000003)
Ferric Maltol
C18H15FeO9 (431.00654299999997)
8-Acetamido-1,1,1,15,15-pentachloropentadeca-3,12-diyne
3-[(4-Iodophenyl)sulfonyl]-2-phenyl-1,3-thiazolidine
cyclopenta-1,3-diene,9H-fluoren-9-ide,propan-2-ylidenezirconium(2+),dichloride
5-bromo-4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide
8-((6-BROMOBENZO[D][1,3]DIOXOL-5-YL)THIO)-9-(PENT-4-YN-1-YL)-9H-PURIN-6-AMINE
C17H14BrN5O2S (431.00515240000004)
TRANS-4-[2-(1-FERROCENYL)VINYL]-1-METHYLPYRIDINIUM IODIDE
2-[(6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo]benzoic acid, sodium salt
7-chloro-N-(3,4-dichlorophenyl)-5-hydroxy-1,1-dioxo-2,3-dihydro-1λ6-benzothiepine-4-carboxamide
C17H12Cl3NO4S (430.9552602000001)
CYCLOPENTADIENYL(FLUORENE)IRON HEXAFLUOROPHOSPHATE
C18H14F6FeP (431.00866560000003)
Acetic acid, 2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, ethyl ester
ethyl5-acetoxy-6-bromo-2-(bromomethyl)-1-methylindole-3-.
Potassium Tetracyanoplatinate(II) Trihydrate
C4H6K2N4O3Pt (430.93618960000003)
Ferric Maltol
C18H15FeO9 (431.00654299999997)
B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AB - Iron trivalent, oral preparations D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
[(1s)-1-(5-Chloro-1-Benzothien-3-Yl)-2-(2-Naphthylamino)-2-Oxoethyl]phosphonic Acid
C20H15ClNO4PS (431.0147910000001)
4-Bromobenzenesulfonic acid (1,3-dioxo-2-benzo[de]isoquinolinyl) ester
C18H10BrNO5S (430.94630300000006)
5-bromo-N-[({4-[(dimethylamino)sulfonyl]phenyl}amino)carbonothioyl]-2-furamide
C14H14BrN3O4S2 (430.96090640000006)
2-[(4-Methylphenyl)sulfonylamino]acetic acid [2-(5-bromo-2-thiophenyl)-2-oxoethyl] ester
C15H14BrNO5S2 (430.94967340000005)
benzthiazide
C15H14ClN3O4S3 (430.98349540000004)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
CMP-5-phosphonoformic acid
C10H15N3O12P2 (431.01309699999996)
A cytidine 5-phosphate obtained by formal condensation of the phosphate group of CMP with the phosphono group of phosphonoformic acid.
N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide
C17H10Cl2F3N3O3 (431.00512860000003)